Prolymphocytic leukaemia 1 T Ooyirilangkumaran MRCP MRcpath (for G W Marsh MD MRcpath) North Middlesex Hospital, London NIB In June 1975 Mr L C, aged 65, presented to the North Middlesex Hospital with recent onset of tiredness, dyspnoea, flatulence, abdominal fullness and bilateral ankle swelling. On examination he was found to be anaemic. Small bilateral inguinal and axillary lymphadenopathy was present. The liver was palpable 2 em, and spleen palpable 13 em, below the costal margin. There were no other abnormal physical signs.
Investigations: Haemoglobin 8.3 g/dl ; white blood count 240000 x 10 6/1; neutrophils 240, lymphocytes 239740, platelets 52000 x 10 6 /1. Blood film: large lymphocytes with relatively well condensed nuclear chromatin and prominent large vesicular nucleoli. Bone marrow aspirate and trephine biopsy: heavy infiltration by lymphocytes similar to those seen in blood. Lymphocyte surface marker studies: surface immunoglobulins positive (IgD and K). Sheep red cell rosettes reduced (10%); mouse rosettes reduced (4%). Fe receptor strongly positive (aggregated r globulin). Lymphangiogram (pedal): enlarged para-aortic nodes with filling defects. Liver function and renal function profile: normal.
Management and progress (Figure 1)
It was proposed to treat this patient by leukapheresis performed in an Aminco continuous flow cell separator. This instrument makes use of the principle of differential density centrifugation for separation of packed red cells from plasma with the leukocyte buffy layer at the interface. At high speeds of centrifugation, the buffy coat consists mainly of lymphocytes, the granulocytes mixing with red cells. The red cells and plasma were returned to the patient whereas the buffy layer was collected and discarded. Although this procedure caused a reduction in the peripheral blood prolymphocyte count, there was no improvement in his platelet count nor in his transfusion requirements. Further, there was no reduction in the spleen size even after nine procedures at fortnightly intervals. It was felt that the large spleen was the probable cause of his anaemia and thrombocytopenia, and splenectomy was the treatment of choice at this stage. Splenectomy was performed on II February 1976. This was followed by an immediate rise in his platelet count to 300 000 X 10 6/1 and a gradual rise of his haemoglobin to 16.0 g/dl without supportive therapy. By August 1976, however, he was noticed to have a 5 cm palpable liver and an increase in the size of his peripheral lymph nodes.
This was accompanied by an increase in the prolymphocytic count to 100000 x 10 6 /1. He was started on chlorambucil at a dose of 10 mg daily continuously. There was a dramatic fall in the peripheral prolymphocyte count and this was accompanied by disappearance of lymph node enlargement and a decrease in size of the liver. The drug was stopped when the white blood count had fallen to 8300 x 10 6 /1. Since off therapy, his white blood count has gradually increased to 22700 x 10 6/1 (50% lymphocytes, 50% neutrophils) without any evidence of hepatomegaly or lymph node enlargement. He remains off therapy.
Discussion
This patient presented with the clinical features reported as typical of prolymphocytic leukaemia, namely moderate splenomegaly with minimal lymphadenopathy (Galton et al. 1974 ). The characteristic haematological features were also described by the same authors: a high leukocyte count comprised almost totally of prolymphocytes with moderately abundant cytoplasm and a nucleus with well condensed chromatin and a prominent nucleolus. This patient's response to splenectomy in combination with leukapheresis is in accordance with the view that this mode of treatment is helpful (Buskard et al. 1976) . The response of these patients to cytotoxic therapy and to splenic irradiation has been reported as poor (Galton et al. 1974 , Catovsky 1977 ). However, we have observed a good response in a previous patient to combination chemotherapy (cyclophosphamide, doxorubicin, vincristine and prednisone) (unpublished), and this urged us to try a single alkylating agent in this patient.
The dramatic fall in the prolymphocyte count together with the reduction in size of the liver and lymph nodes indicate the remarkable sensitivity of this patient's prolymphocytes to chlorambucil. It is possible that the cells are more sensitive to cytotoxic therapy after the spleen is removed. The possibility that the prolymphocytes may be of splenic origin has been raised (Galton et al. 1974) . Splenectomy, in addition to removing a large mass of tumour, could also be removing a preferential site for proliferation of the prolymphocytes.
